{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["Effects", "of", "1", "alpha", ",", "25-dihydroxyvitamin", "D3", "on", "the", "human", "chronic", "myelogenous", "leukemia", "cell", "line", "RWLeu-4", "."], "sentence": "Effects of 1 alpha , 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4 .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["The", "effects", "of", "1", "alpha", ",", "25-dihydroxyvitamin", "D3", "(", "VD3", ")", "on", "proliferation", ",", "differentiation", ",", "and", "macromolecular", "synthesis", "in", "the", "new", "Philadelphia", "chromosome", "-", "positive", "chronic", "myelogenous", "leukemia", "cell", "line", ",", "RWLeu-4", ",", "were", "investigated", "."], "sentence": "The effects of 1 alpha , 25-dihydroxyvitamin D3 ( VD3 ) on proliferation , differentiation , and macromolecular synthesis in the new Philadelphia chromosome - positive chronic myelogenous leukemia cell line , RWLeu-4 , were investigated .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["Binding", "of", "[", "3H", "]", "VD3", "was", "saturable", ",", "with", "approximately", "2000-3000", "sites", "/", "cell", ",", "and", "half", "-", "maximal", "binding", "occurring", "at", "0.21-0.33", "nM", "."], "sentence": "Binding of [ 3H ] VD3 was saturable , with approximately 2000-3000 sites / cell , and half - maximal binding occurring at 0.21-0.33 nM .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["Treatment", "of", "RWLeu-4", "cells", "with", "VD3", "induced", "24R-hydroxylase", "activity", ",", "a", "marker", "of", "vitamin", "D3", "responsiveness", "in", "many", "tissues", "."], "sentence": "Treatment of RWLeu-4 cells with VD3 induced 24R-hydroxylase activity , a marker of vitamin D3 responsiveness in many tissues .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["Exposure", "of", "RWLeu-4", "cells", "to", "VD3", "also", "inhibited", "proliferation", "and", "DNA", "synthesis", "with", "a", "50", "%", "effective", "dose", "of", "3.5-10", "nM", "within", "72", "h", ";", "in", "addition", ",", "protein", "and", "RNA", "synthesis", "were", "inhibited", "by", "VD3", "treatment", "."], "sentence": "Exposure of RWLeu-4 cells to VD3 also inhibited proliferation and DNA synthesis with a 50 % effective dose of 3.5-10 nM within 72 h ; in addition , protein and RNA synthesis were inhibited by VD3 treatment .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["Exposure", "of", "RWLeu-4", "cells", "to", "5", "nM", "VD3", "for", "72", "h", "caused", "50", "%", "of", "the", "cells", "to", "differentiate", "into", "macrophage", "/", "monocyte", "type", "cells", "as", "judged", "by", "nitroblue", "tetrazolium", "staining", "and", "adherence", "to", "plastic", "."], "sentence": "Exposure of RWLeu-4 cells to 5 nM VD3 for 72 h caused 50 % of the cells to differentiate into macrophage / monocyte type cells as judged by nitroblue tetrazolium staining and adherence to plastic .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["Progressive", "expression", "of", "cell", "surface", "maturation", "-", "specific", "antigens", "of", "the", "monocyte", "/", "macrophage", "lineage", "was", "induced", "by", "treatment", "of", "RWLeu-4", "cells", "with", "VD3", "for", "24", "to", "72", "h", "at", "doses", "that", "inhibited", "cellular", "proliferation", "."], "sentence": "Progressive expression of cell surface maturation - specific antigens of the monocyte / macrophage lineage was induced by treatment of RWLeu-4 cells with VD3 for 24 to 72 h at doses that inhibited cellular proliferation .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-2159372.txt", "sent_id": "S8", "tokens": ["c-myc", "RNA", ",", "which", "is", "constitutively", "expressed", "in", "RWLeu-4", "cells", ",", "increased", "after", "0.5", "h", "of", "treatment", "with", "50", "nM", "VD3", "and", "then", "rapidly", "decreased", "to", "barely", "detectable", "levels", "after", "4", "h", "of", "treatment", "."], "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "c-myc", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMID-2159372.txt", "sent_id": "S9", "tokens": ["Finally", ",", "the", "in", "vitro", "tyrosine", "kinase", "activity", "associated", "with", "the", "p210bcr-abl", "oncogene", "product", "was", "decreased", "approximately", "50", "%", "by", "VD3", "treatment", "."], "sentence": "Finally , the in vitro tyrosine kinase activity associated with the p210bcr-abl oncogene product was decreased approximately 50 % by VD3 treatment .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "p210bcr-abl oncogene", "entity_type": "Protein", "start": 11, "end": 12}]}
{"doc_id": "PMID-2159372.txt", "sent_id": "", "tokens": ["Because", "of", "the", "presence", "of", "a", "functional", "receptor", "-", "effector", "system", "for", "VD3", "and", "multiple", "biological", "responses", "to", "the", "hormone", ",", "these", "cells", "provide", "a", "unique", "model", "system", "with", "which", "to", "probe", "the", "specific", "effects", "of", "VD3", "on", "cell", "growth", "and", "differentiation", "in", "chronic", "myelogenous", "leukemia", "."], "sentence": "Because of the presence of a functional receptor - effector system for VD3 and multiple biological responses to the hormone , these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .", "event_mentions": [], "entity_mentions": []}
